ArticleCancer cell2017

Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma.

Veronica Veschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.